Skip to content
Sections in this chapter

§ 360aa. Recommendations for investigations of drugs for rare diseases or conditions

  • (a) The sponsor of a drug for a disease or condition which is rare in the States may request the Secretary to provide written recommendations for the non-clinical and clinical investigations which must be conducted with the drug before—
    • (1) it may be approved for such disease or condition under section 355 of this title , or
    • (2) if the drug is a biological product, it may be licensed for such disease or condition under section 262 of title 42 .
  • (b) The Secretary shall by regulation promulgate procedures for the implementation of subsection (a).
OpenLaw Git Workbench

Statutory Version Intelligence & Diffs

Quick Presets:
0 official releases tracked